Kazuhiro Tahara

Eisai (Japan) — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

3h-index41citations52works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Angiogenesis and VEGF in Cancer(20), Developmental Biology and Gene Regulation(18), Microtubule and mitosis dynamics(14), RNA Research and Splicing(9), Cancer Cells and Metastasis(4)

Publications52 total

Quantification of EphA4 Turnover Rate and Subsequent Validation of Target Engagement for E2025, a Novel Anti‐EphA4 Antibody, in Human Neural Cells
Alzheimer s & Dementia·2025Open Access
Target Engagement of Lecanemab on CSF Aβ Protofibril Toxic Species in Clarity AD
Alzheimer s & Dementia·2025Open Access
Supplementary Figure S2 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2025Open Access
Supplementary Figure S1 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2025Open Access
Supplementary Figure S3 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2025Open Access
Supplementary Table 1 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2025Open Access
Supplementary Figure S4 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2025Open Access
Correction: Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
Cancer Research Communications·2025Open Access
Supplementary Figure S4 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2025Open Access
Supplementary Figure S1 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2025Open Access
Supplementary Figure S2 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2025Open Access
Supplementary Figure S3 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2025Open Access
Supplementary Table 1 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2025Open Access
Supplementary Figure S1 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2024Open Access
Supplementary Figure S2 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2024Open Access
Supplementary Table 1 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2024Open Access
Supplementary Table 1 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2024Open Access
Supplementary Figure S1 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2024Open Access
Supplementary Figure S4 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2024Open Access
Supplementary Figure S3 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Yoshimasa Sakamoto(45), Youya Nakazawa(45), Sho Tachino(45), Ken Ito(45), Yukinori Minoshima(45), Kana Hoshino‐Negishi(45), Tomomi Kawakatsu(45), Miyuki Nishimura(45), Toshitaka Sato(45), Katsuhisa Suzuki(45), Kishan Agarwala(45), Masao Iwata(45), Yoichi Ozawa(45), Toshio Imai(45), Yasuhiro Funahashi(45), Jason W.‐L. Eng(44), Yu Kato(44), Yusuke Adachi(44), Bhairavi Swaminathan(44), L.A. Naiche(44)